Shared Genetic Pathways Contribute to Risk of Hypertrophic and Dilated Cardiomyopathies with Opposite Directions of Effect

The heart muscle diseases hypertrophic (HCM) and dilated (DCM) cardiomyopathies are leading causes of sudden death and heart failure in young, otherwise healthy, individuals. We conducted genome-wide association studies and multi-trait analyses in HCM (1,733 cases), DCM (5,521 cases) and nine left ventricular (LV) traits (19,260 UK Biobank participants with structurally normal hearts). We identified 16 loci associated with HCM, 13 with DCM and 23 with LV traits. We show strong genetic correlations between LV traits and cardiomyopathies, with opposing effects in HCM and DCM. Two-sample Mendelian randomization supports a causal association linking increased LV contractility with HCM risk. A polygenic risk score explains a significant portion of phenotypic variability in carriers of HCM-causing rare variants. Our findings thus provide evidence that polygenic risk score may account for variability in Mendelian diseases. More broadly, we provide insights into how genetic pathways may lead to distinct disorders through opposing genetic effects.

Citing Articles

Sequencing in over 50,000 cases identifies coding and structural variation underlying atrial fibrillation risk.

Choi S, Jurgens S, Xiao L, Hill M, Haggerty C, Sveinbjornsson G Nat Genet. 2025; 57(3):548-562.

PMID: 40050430 DOI: 10.1038/s41588-025-02074-9.

Genome-wide association study meta-analysis provides insights into the etiology of heart failure and its subtypes.

Henry A, Mo X, Finan C, Chaffin M, Speed D, Issa H Nat Genet. 2025; .

PMID: 40038546 DOI: 10.1038/s41588-024-02064-3.

Large-scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy.

Tadros R, Zheng S, Grace C, Jorda P, Francis C, West D Nat Genet. 2025; 57(3):530-538.

PMID: 39966646 PMC: 11906354. DOI: 10.1038/s41588-025-02087-4.

Evaluation of polygenic scores for hypertrophic cardiomyopathy in the general population and across clinical settings.

Zheng S, Jurgens S, McGurk K, Xu X, Grace C, Theotokis P Nat Genet. 2025; 57(3):563-571.

PMID: 39966645 PMC: 11906360. DOI: 10.1038/s41588-025-02094-5.

Eccentric hypertrophy impairs outcome after TAVR.

Thalmann R, Obermeier V, Westphal D, Diebold I, Trenkwalder T, Pellegrini C Clin Res Cardiol. 2024; .

PMID: 39652119 DOI: 10.1007/s00392-024-02582-4.

References

Lee S, Wray N, Goddard M, Visscher P . Estimating missing heritability for disease from genome-wide association studies. Am J Hum Genet. 2011; 88(3):294-305. PMC: 3059431. DOI: 10.1016/j.ajhg.2011.02.002. View

Aung N, Vargas J, Yang C, Cabrera C, Warren H, Fung K . Genome-Wide Analysis of Left Ventricular Image-Derived Phenotypes Identifies Fourteen Loci Associated With Cardiac Morphogenesis and Heart Failure Development. Circulation. 2019; 140(16):1318-1330. PMC: 6791514. DOI: 10.1161/CIRCULATIONAHA.119.041161. View

Kramer C, Appelbaum E, Desai M, Desvigne-Nickens P, DiMarco J, Friedrich M . Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy. Am Heart J. 2015; 170(2):223-30. PMC: 4548277. DOI: 10.1016/j.ahj.2015.05.013. View

Wooten E, Hebl V, Wolf M, Greytak S, Orr N, Draper I . Formin homology 2 domain containing 3 variants associated with hypertrophic cardiomyopathy. Circ Cardiovasc Genet. 2012; 6(1):10-8. PMC: 3578062. DOI: 10.1161/CIRCGENETICS.112.965277. View

Vriesendorp P, Liebregts M, Steggerda R, Schinkel A, Willems R, Ten Cate F . Long-term outcomes after medical and invasive treatment in patients with hypertrophic cardiomyopathy. JACC Heart Fail. 2014; 2(6):630-6. DOI: 10.1016/j.jchf.2014.06.012. View

Petersen S, Matthews P, Francis J, Robson M, Zemrak F, Boubertakh R . UK Biobank's cardiovascular magnetic resonance protocol. J Cardiovasc Magn Reson. 2016; 18:8. PMC: 4736703. DOI: 10.1186/s12968-016-0227-4. View

Esslinger U, Garnier S, Korniat A, Proust C, Kararigas G, Muller-Nurasyid M . Exome-wide association study reveals novel susceptibility genes to sporadic dilated cardiomyopathy. PLoS One. 2017; 12(3):e0172995. PMC: 5351854. DOI: 10.1371/journal.pone.0172995. View

Bowden J, Davey Smith G, Haycock P, Burgess S . Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol. 2016; 40(4):304-14. PMC: 4849733. DOI: 10.1002/gepi.21965. View

Braz J, Gregory K, Pathak A, Zhao W, Sahin B, Klevitsky R . PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat Med. 2004; 10(3):248-54. DOI: 10.1038/nm1000. View

10.

Yang J, Bakshi A, Zhu Z, Hemani G, Vinkhuyzen A, Lee S . Genetic variance estimation with imputed variants finds negligible missing heritability for human height and body mass index. Nat Genet. 2015; 47(10):1114-20. PMC: 4589513. DOI: 10.1038/ng.3390. View

11.

Loh P, Tucker G, Bulik-Sullivan B, Vilhjalmsson B, Finucane H, Salem R . Efficient Bayesian mixed-model analysis increases association power in large cohorts. Nat Genet. 2015; 47(3):284-90. PMC: 4342297. DOI: 10.1038/ng.3190. View

12.

de Leeuw C, Mooij J, Heskes T, Posthuma D . MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput Biol. 2015; 11(4):e1004219. PMC: 4401657. DOI: 10.1371/journal.pcbi.1004219. View

13.

Hartwig F, Davey Smith G, Bowden J . Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017; 46(6):1985-1998. PMC: 5837715. DOI: 10.1093/ije/dyx102. View

14.

Bulik-Sullivan B, Loh P, Finucane H, Ripke S, Yang J, Patterson N . LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet. 2015; 47(3):291-5. PMC: 4495769. DOI: 10.1038/ng.3211. View

15.

Bulik-Sullivan B, Finucane H, Anttila V, Gusev A, Day F, Loh P . An atlas of genetic correlations across human diseases and traits. Nat Genet. 2015; 47(11):1236-41. PMC: 4797329. DOI: 10.1038/ng.3406. View

16.

Hemani G, Zheng J, Elsworth B, Wade K, Haberland V, Baird D . The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018; 7. PMC: 5976434. DOI: 10.7554/eLife.34408. View

17.

Stokke T, Hasselberg N, Smedsrud M, Sarvari S, Haugaa K, Smiseth O . Geometry as a Confounder When Assessing Ventricular Systolic Function: Comparison Between Ejection Fraction and Strain. J Am Coll Cardiol. 2017; 70(8):942-954. DOI: 10.1016/j.jacc.2017.06.046. View

18.

Meder B, Ruhle F, Weis T, Homuth G, Keller A, Franke J . A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy. Eur Heart J. 2013; 35(16):1069-77. DOI: 10.1093/eurheartj/eht251. View

19.

Green E, Wakimoto H, Anderson R, Evanchik M, Gorham J, Harrison B . A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice. Science. 2016; 351(6273):617-21. PMC: 4784435. DOI: 10.1126/science.aad3456. View

20.

Zhu Z, Zheng Z, Zhang F, Wu Y, Trzaskowski M, Maier R . Causal associations between risk factors and common diseases inferred from GWAS summary data. Nat Commun. 2018; 9(1):224. PMC: 5768719. DOI: 10.1038/s41467-017-02317-2. View